Lilly’s Retatrutide Raises Weight-Loss Bar In First Phase III Readout

 
• By Joseph Haas
  
This is a picture of the Lilly building in San Diego
Lilly's retatrutide reported its first Phase III data, showing weight loss, knee pain improvement (Shutterstock)

More from Strategy

More from Business